CN104434781A - Application of allicin injection in preparation of medicines for treating infectious diseases caused by fungi/bacteria - Google Patents
Application of allicin injection in preparation of medicines for treating infectious diseases caused by fungi/bacteria Download PDFInfo
- Publication number
- CN104434781A CN104434781A CN201410622901.4A CN201410622901A CN104434781A CN 104434781 A CN104434781 A CN 104434781A CN 201410622901 A CN201410622901 A CN 201410622901A CN 104434781 A CN104434781 A CN 104434781A
- Authority
- CN
- China
- Prior art keywords
- allicin
- antibacterial
- bulbus allii
- preparation
- fungus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The invention relates to the technical field of application of allicin, and particularly relates to application of allicin injection in preparation of medicines for treating infectious diseases caused by fungi/bacteria. Antibacterial activity tests on allicin indicate that allicin has a certain effect on antibacterial activity of fungi or bacteria, and further prove that the allicin injection can become a novel medicine preparation for effectively treating infectious diseases caused by fungi/bacteria. Moreover, allicin serving as a natural substance does not have toxic or side effect, has the effects of safety, reliability and good curative effect when used as medicines for treating infectious diseases caused by fungi/bacteria.
Description
Technical field
The present invention relates to the applied technical field of allicin, is that a kind of allicin injection causes the application of infectious disease medicament as preparation treatment fungus/antibacterial.
Background technology
Since ancient times, Bulbus Allii (
allium sativum L) be different regions, the world, different nationalities generally acknowledge medicine food dual purpose plant.B.C., the record that the archaeological information and medical literature of ancient Egypt, ancient Gingko, ancient Roman just have many Bulbus Alliis medicinal.Ancient Times in China, Bulbus Allii is common drug.Record in Compendium of Material Medica: Bulbus Allii " logical the five internal organs, reach all keys, and cold removing wets, and exorcise evil spirits evil, subduing inflammation ", " only cholera, evil removing is haunt and plague, separates pestilence, removes diseases due to noxious agents produced by various parasites, malignant boil, snakeworm, small stream poison ", " journey taken, then scorching wind miasma rain can not add, and eating brave cured poison can not do harm to ".CHEN Zang-Qi is said: " Bulbus Allii just eats unfavorable order, and polyphagia is bright, and food of a specified duration makes us serum ".Uygur medicine treatise is recorded: be used for the treatment of the various diseases such as qi and blood stagnation, pharyngolaryngitis, apoplexy, hemiplegia, convulsions, joint aches.A method of Garlic in Treatment hemiplegia recorded by dimension doctor ancient books: within the 1st day, eat 1, Bulbus Allii raw, increase day by day 1, ate 20 raw to the 20th day.After this subtract 1 day, 39 days is a course for the treatment of, has special effect.
In modern age, Bulbus Allii is mainly used as antibacterials.During the World War I, Bulbus Allii is widely used as anticorrosion and antimicrobial drug.In generation nineteen thirty, finds that hundred bright many breaths have antibacterial effect; Nineteen thirty-seven synthesis sulfapyridine; Nineteen thirty-nine synthesis sulfathiazole; Nineteen forty-one synthesis sulfadiazine; Nineteen twenty-eight Fleming discovery penicillin (MIT bavin grace, Florey extracted in 1938) comes out; In generation nineteen sixty, semi-synthetic, synthetic antibiotic was come out one after another, and various infectious disease is controlled substantially, and the pharmaceutical purposes of Bulbus Allii sharply reduces afterwards.But, after this find multiple bacterial strain can produce drug resistance to antibiotics, undesirable and multiple side effect may be produced, therefore nineteen fifty to 1980 year to the effect of fungus, among the peoplely do not stop using Bulbus Allii to cure the disease.Some large hospitals, adopt vapor distillation to prepare Bulbus Allii quintessence oil and injection, and treatment fungal infection also obtains good efficacy.The 1980's found, the cardiovascular and cerebrovascular disease that garlic active ingredient is the highest to world's M & M also demonstrates good curative effect.
The botany research of Bulbus Allii: 1, plant classification ownership: in the age how named for Bulbus Allii (Allium sativum L.) woods, plant classification method is still incomplete.The morphological characteristic of Bulbus Allii and Allium, Lycoris, Anemarrhena and lilium are relatively, but it is very inadequate to belong to Liliaceae (Liliaceae), 1987, the botanists such as Takhtajan are by the Allium independence Cheng Cong section in former Liliaceae, the umbel solving Herba Alii fistulosi section and the involucre be made up of bract are similar to Amaryllidaceae, and the contradiction that its ovary epigynous flower is identical with liliaceous ovary epigynous flower, and accepted by each authoritative institution, Allium is under the jurisdiction of Herba Alii fistulosi section (Alliaceae), thus, the ownership of Bulbus Allii plant classification, should be revised as: " Herba Alii fistulosi section (Alliaceae) plant Bulbus Allii (Allium sativum L.) ", or broad sense Liliaceae, 2, the kind of Bulbus Allii: 2.1, the classification of the kind of Bulbus Allii: whole world Bulbus Allii only has the saying of a kind " Allium sativum L. " inaccurate, it was reported, Bulbus Allii has 600 multi items in the current whole world, (1), morphological classification (morphology, cytology), Regel (1875) and Vedensky (1968) thinks it is A.1ongicuspis the ancestors of Bulbus Allii, Helm (1956) is divided into 3 mutation: Longicuspis (long plush copper), ophioscordon (Serpentis Bulbus Allii) and sativum, Kazakova (1971 to 1978) separates again two subspecies: Subtropical (subtropical zone) and Pekinense (Beijing) totally 5 kinds, due to the difference that varying environment causes, produce again many novel species.By color of the leather, can be divided into Rhizoma Euonymus Bulbus Allii and purple garlic, Rhizoma Euonymus Bulbus Allii tolerance to cold is strong, general sowing in late fall, principal item has 23 kinds, purple garlic crust aubergine, and lobe is fertile, number is few, general sowing in early spring, (2), Phytochemistry classification principal item has 26 kinds, and, cysteine derivative is the total plant chemical ingredient of different cultivars Bulbus Allii, cysteine-sulfide has important systematics meaning, is divided into three classes: 1), cysteine-sulfide content is high, 2), cysteine-sulfide content is low, 3), based on alliin and different alliin (isoalliin), (3), classification by use, Seedling type, a kind of sedge type, head type, Seedling a kind of sedge dual-purpose type, the climing dual-purpose type of head a kind of sedge dual-purpose type head Seedling, 2.2, molecular biology method classification (molecular marker) confirms the original producton location of Bulbus Allii, Vavilov (1926), Kazakova (1971) thinks that the Central Asia is the centre of origin of Bulbus Allii, Etoh (1986), Kotlinska (1991), Kamenetsky (2004) etc. find at Central Asia Tianshan Mountains the archetype that Bulbus Allii can educate, support that the Central Asia is the Bulbus Allii centre of origin, verified by biochemical and the molecular marker analysis such as Pooler (1993) and Hong (1999) subsequently, Bulbus Allii is inaccurate from the external saying introduced, 3, Bulbus Allii is original, Wu Zhengyi etc., new plant resources categorizing system is proposed: Xinjiang has the wild economic plant germ plasm resource of Important Economic potentiality, comprise: the vegetable wild relativeses such as Herba Alii fistulosi, Bulbus Allii, fragrant-flowered garlic, there is the prospect of exploitation further, 1996 to 1998, Xinjiang academy of agricultural sciences Lu Jun Jun etc., collect, investigate, find multiple Bulbus Allii, the display Mountain Ranges of Tian Shan Mountains is the main distributed areas of Allium Garlic Germplasm Resources.
The effective ingredient of Bulbus Allii:
1, garlicin compound: because some bacterial strains produce drug resistance to antibiotics, and the effect of antibiotic to fungus is undesirable, among the peoplely Bulbus Allii is not stopped using to cure the disease, some large hospitals, vapor distillation is adopted to prepare Bulbus Allii quintessence oil and injection, treatment fungal infection obtains good efficacy, 1972 to 1976, Shanghai Mr. Lang Yijiang etc., be separated from Bulbus Allii vapor distillation quintessence oil and obtain a kind of oily yellow liquid, physicochemical property is more stable, the strong Bulbus Allii of tool is smelly, through GC, HPLC separation and purification, IR, the Analysis and Identification such as MS, confirm as trisulfide (Alliitridum), (Lang Yijiang, Deng, garlic active ingredient is studied, Chinese herbal medicine communication, 1981, 12 (1): 4), this achievement in research is in advanced level both at home and abroad, and pharmacological experiment display has the pharmacological action of similar Bulbus Allii composition, once called after allicin, standard called after garlicin in 2002,
2, after the results of study such as Lang Yijiang are delivered 10 years, moral, beautiful, Israel, the states such as Japan find, the cardiovascular and cerebrovascular disease that garlic active ingredient is the highest to world's M & M has good curative effect, cause world's extensive concern, start the climax of Bulbus Allii research, the experimental results shows, alliin (Alliin), allinase (Alliinase) and allicin (Allicin) are Bulbus Allii infection, prevent and treat the main composition of cardio-cerebrovascular diseases, alliin and allicin are by the U.S., the multinational pharmacopeia such as Britain/European Union confirm as Bulbus Allii and preparation is differentiated and the leading indicator of assay, and Chinese Pharmacopoeia and relevant criterion still use " garlicin (garlicin compound) " as the index of quality control, thus, define two kinds of " medicinal Bulbus Allii " quality index systems in the world, (1), alliin (Alliin, CAS:556-27-24), chemical name: SACS (S-Allyl-L-cysteine sulfoxide), mp:163 DEG C to 165 DEG C, [α] D=+60o, white filament crystal.1948 by Stoll and Seeback separation andpreconcentration [26] first from Bulbus Allii.Being present in Bulbus Allii bulbil with odorless form, is the sulfur-containing amino acid the most original, most important in Bulbus Allii unicorn bud, content is the highest.Content has very big-difference (0.3-2.5%) (note: the U.S.'s " chemical abstracts because of kind and the place of production, CA " society, in order to solve " multiple compound is of the same name; or same compound is several " a difficult problem, a coding to each compound provides), (2), alliin lyase (Alliinase, EC 4.4.1.4, CAS:9031-77-0) has another name called allinase, Alkylcysteine sulfoxide lyase (S-allyl-L-cysteine sulfoxide lyase).Belong to dimer glycoprotein, two molecular weight subunits are 51.5 KDa.The domain (blueness) combined by N-terminal domains (yellow), P5P and C-terminal domains (redness) form, crystallization is in yellow, odorless, isoelectric pH: 4.9, to responsive to temperature (EC 4.4.1.4: international EC is to the coding of allinase.First digit 4 represents that this enzyme belongs to the fourth-largest class (lyase), second digit 4 represents genus the 4th subclass (Alkylcysteine sulfoxide lyase), third digit 1 represents genus first group, fourth digit 4 represents the sequence number finding this enzyme), (3), allicin (Allicin, CAS:539-86-6), chemical name: GIUCOSinoate (Diallyl thiosulfinate), MW:162.3, BP:28 DEG C (decomposition), be slightly soluble in water, there is Bulbus Allii taste, first nineteen forty-four Cavallito with Bailey be separated and obtain from the garlic juice pulverized, that the product closing substrate alliin is split in allinase catalysis, it is the most important bioactive ingredients of Bulbus Allii, but unstable chemcial property, at room temperature, in air, namely a few hours decompose rotten.
Garlicin (Allitridum, CAS:2050-87-5): the national drug standards " WS-10001-(HD-0050)-2002 " garlicin is defined as to " allicin, containing C
6h
10s
3should be 97%-103% ", allicin, once called after " allicin (Allitride).Within 2002, the national drug standards rename as garlicin.State-promulgated pharmacopoeia (2015 editions) is continued to use.Continue the content of allicin height, as the standard directly passing judgment on Bulbus Allii medical material and the quality of the pharmaceutical preparations, by " allicin " called after garlicin, from now (after standard formulation 30 years), there is the defect of hastily and easily misunderstanding, one is the systematic study not yet completing Bulbus Allii at that time, two is principle active component garlicin being regarded as Bulbus Allii, misleading experimenter adopts chemical reagent to carry out pharmacodynamics test, Bulbus Allii vegetable drug is replaced with chemical reagent, produce Bulbus Allii pharmaceutical preparation and plurality kinds of health care product, China broad masses are made to fail to enjoy the real medical treatment of plant Bulbus Allii and health-care effect, the garlic preparation of China is made to lag behind the world, therefore, China's Bulbus Allii relevant criterion should grow with each passing hour, revise as early as possible.
The chemical constitution of garlicin, alliin, allicin is different: alliin, garlicin and allicin, and chemically the aspect such as structure, chemical abstracts numbering, physicochemical property, biological activity is three kinds of different compounds, must eliminate the false and retain the true.
Allicin (Allicin, CAS:539-86-6), chemical name: GIUCOSinoate (Diallyl thiosulfinate), MW:162.3, BP:28 DEG C (decomposition), be slightly soluble in water, have garlicky, first nineteen forty-four Cavallito with Bailey be separated and obtain from the garlic juice pulverized, that the product closing substrate alliin is split in allinase catalysis, the most important bioactive ingredients of Bulbus Allii, but unstable chemcial property, in room temperature, air, namely a few hours decompose rotten.
Garlicin has moderately toxic chemical industry sintetics: garlicin (Allitridum), the another name: (Allisatin such as Diallytrisin, trisulfides two propylene, diallyl trisulfide, Allitrid, Diallyl trisulfide), be a kind of reagent of chemosynthesis, be once used as chemosynthesis intermediate, paint thinner.Yellow flammable liquid, purity: 50-99%; Garlicin toxicity rank: in (Hazard Class:6.1-b, Poisonous/Toxic Materials), acute toxicity: Mouse oral LD50:100 mg/Kg, quiet note LD50:70mg/kg, Oral Administration in Rats LD50:265mg/kg, hazardous materials transportation number: 2810 [37]; Hunan Jing Tian scientific & technical corporation produces synthetic allicin 1000 tons per year, workshop-sink flows to Xiang River with rainwater, institute is to the greatest extent withered through part vegetation, cattle is dead because of the grass near Chi Liao factory, the fish of neighbouring Xiang River cultivation, all wonder death, through Hunan, refined hospital diagnosis is the poisoning neuropathy caused to several millworker.Effect of the biological activity of garlicin not On behalf of plant Bulbus Allii and preparation thereof, experiment display, Bulbus Allii have many-sided drug effect, but can not On behalf of plant Bulbus Allii main component alliin and the drug effect of allicin and the effect of clinical practice, due to the misunderstanding formed for a long time, replace the effective ingredient of Natural Garlic to make health food and medicine with toxic chemical, make China broad masses fail to enjoy the achievement in research of plant Bulbus Allii in modern age, many infringements are caused to consumer.Therefore, " Allitridum ", " Allicin " both documents, pharmacology, toxicity and clinical practice etc. are lumped together, causes many misunderstandings at home and abroad.Further, the effective ingredient in the capsulae allitridi of current clinical practice or garlicin injection is not " Diallytrisin " single component, but one group of mixture.Not containing garlicin in fresh Bulbus Allii, garlicin is all synthetic, is not the effective ingredient of Bulbus Allii.Garlicin is completely different from the chemical constitution of alliin or allicin." Diallytrisin " is called " garlicin ", is a gross mistake.People is takeed for " effective ingredient that garlicin is Bulbus Allii ", therefore " garlicin can extract from fresh Bulbus Allii " especially one do not have valid misunderstanding, misleading or guess.As shown in Figure 2, Figure 3, Figure 4, can compare the chemical constitution of alliin, allicin and garlicin; Further, as shown in Figure 5, the relation of alliin, allinase, allicin and diallyl sulfide (ally sulfides) can be understood.
Alliin, Bulbus Allii is the plant that in known edible plant, sulfur amino acid content is the highest, and wherein alliin accounts for more than 70% of whole sulfur-containing amino acid, has 5% to 6% for sulfur-containing amino acid in the essential amino acids of human body.Body itself can not synthesize sulfur-containing amino acid, must from external absorption.Alliin is metabolism in vivo, participates in the synthesis of glutathion (GSH) directly.Glutathion (GSH) is a kind of tripeptides, by cysteine (cysteine), glutamic acid (glutamic acid) and glycine (glycine forms), there is immunostimulant (enhancer), function such as removing toxic substances (detoxifier) and antioxidation (antioxidant) etc., thus performance drug effect, resist the invasion of pathogen, the generation of prevention cardiovascular and cerebrovascular disease and adjuvant therapy of tumors.
Allinase (allinase), has another name called " Alkylcysteine sulfoxide lyase ", and cooperation use is split in the catalysis C-S key of compound to mild condition, has certain effect for control " homocysteine hypercalcinuria ".The rising of homocysteine (homocysteine, Hcy) level in blood, is a risk factor of the vascular conditions morbidities such as atherosclerosis, and is obvious dose-dependence with Atheromatosis feelings.And initiating link important in the vascular endothelium dysfunction that Hcy mass formed by blood stasis the causes early stage pathogenic process that is atherosclerosis.Allinase may become " future " medicine of control homocysteine hypercalcinuria.Unfortunately, current most researcher non-existent in fresh Bulbus Allii " garlicin (Diallytrisin) " is as object of study.
1., alliin (Alliin) American Pharmacopeia and European Union pharmacopeia confirm that the principle active component of Bulbus Allii (Alliium sativum L.) is:, chemical name: SACS (S-Allyl-L-cysteine); 2., allinase (Alliinase, EC 4.4.1.4), have another name called alliin lyase (Alliin lyase); 3., allicin (Allicin) chemical name of allinase catalytic pyrolysis alliin generation: GIUCOSinoate (Diallyl thiosulfinate), due to the extraction of allicin and preparation technique very difficult and complicated, therefore research and develop the study hotspot that safe, effective, quality controllable allicin preparation becomes pharmacy man of various countries.
Fresh Bulbus Allii is cut or after smashing to pieces, alliin wherein and allinase meet, by rapid catalytic reaction generating allicin, allicin is unstable with the physicochemical property in air at normal temperatures, from fresh Bulbus Allii, therefore extract alliin, allinase and preparation " alliin+allinase " solid preparation and allicin injection very difficult.Allinase catalytic pyrolysis alliin produces the relational expression schematic diagram of allicin as shown in Figure 1, and the present invention relates to altogether and adopts four patent of invention technology:
(1) production technology, extracting alliin from fresh Bulbus Allii is the Chinese patent literature of 1425650 with reference to publication number;
(2) production technology, extracting allinase from fresh Bulbus Allii is the Chinese patent literature of 1424397 with reference to publication number;
(3), the preparation method of alliin reference substance is the Chinese patent literature of 101560174 with reference to publication number;
(4), a kind of preparation method of allicin injection is the Chinese patent literature of 102058527A with reference to publication number.
Large quantity research shows that allicin plays an important role in the antimicrobial acivity of Bulbus Allii.To in cardiovascular disease prevention and therapy, Bulbus Allii has blood fat reducing, antithrombotic, blood pressure lowering and prevents and treats the effects such as atherosclerosis, and mechanism of action is the organic sulfur compound I being derived from Bulbus Allii) by suppressing one very important enzyme-HMG-CoA reductase in cholesterol biosynthesis process to suppress cholesterol biosynthesis; II) can anticoagulant; III) suppress the enzyme caused inflammation that plays an important role in cardiovascular disease pathology, i.e. the activity of epoxidase and lipoxygenase, reduce the expression of nitric oxide synthetase (iNOS) derivant in inflammatory leukocytes (macrophage); IV) suppress propagation and the transfer of vascular smooth muscle cell; V) antioxidant-glutathione in important vascular cell can be synthesized and have and have antioxidant activity.
Draw according to France and clap commercialization garlic products (2 × Austria that thunder (Rabelais) university I. Arnault and J. Auger etc. [81] 2004 years is active component with Bulbus Allii powder to 11 of European countries, 1 × Germany, 2 × Italy, 3 × Sweden, 1 × Britain, German examined product is wherein only had to have medicine qualification) analysis carried out, result shows, what the composition of most of Bulbus Allii powder product and their manufacturer declared greatly differs from each other.Neither one product stability reaches 90% limit standard of medicine code requirement, and most products has dropped to less than 50% of assessment values.
So in order to prevent and treat critical illness, clinical requirement effective ingredient reaches high-load to guarantee curative effect.For this reason, the scholar of the minority developed countries such as U.S., moral, Israel, France is starting to adopt the advanced technology such as freezing, vacuum drying, ion exchange, membrance separation, cost great effort research and development " the efficient novel formulation of Bulbus Allii ".But be still in development at present, there is no " the efficient novel formulation of Bulbus Allii " product both at home and abroad and release.
Allicin is most important infection effective ingredient, and experimentation shows, and allicin has the activity of anti-multiple malignant bacteria (helicobacter pylori etc.), fungus (Candida albicans) etc. and virus.Especially effective to pathogen such as the pathogenic bacterium of several drug resistance, allicin can produce NO and H
2the chemical mediators such as S, have reduction leukocyte adhesion, reduce the function such as apoptosis, antioxidation and play curative effect.
Antibacterium medicine, also referred to as " antibacterial agent ", is that a class is for bacteria growing inhibiting or the medicine killing antibacterial.When not causing ambiguity, antibacterium medicine also can referred to as " antimicrobial drug ".What antibiotic was produced by microorganism (comprising antibacterial, fungus, actinomyces) has the class secondary metabolite suppressing other quasi-microorganism to grow, survive, and chemically synthesizes or semisynthetic similar compound.Definition is a wider concept, comprises antibacterium antibiotic, antifungal antibiotic and tackle the antibiotic of other small cause of diseases; But in clinical practice, antibiotic usually refers to antibacterium antibiotic.
The antibiosis used as antibacterial have following primary categories: penicillin, cephalosporin, aminoglycoside antibiotics, macrolide antibiotics, tetracycline antibiotics, chloromycetin, in addition, have neither microorganism secretion thing is not again the artificial complete synthesis antibacterial of its analog: quinolinones and sulfa drugs, but, these medicines in use, penicillin easily causes gastrointestinal upset and diarrhoea, severe allergy, once in a while brain and Toxicity of Kidney occurs; Cephalosporin easily causes the uncomfortable and diarrhoea of digestive tract, if can cause nauseating with ethanol with taking, also allergic phenomena can occur; Aminoglycoside antibiotics easily causes damage to audition, also can occur dizzy, even cause nephrotoxicity; When macrolide antibiotics heavy dose uses, common nausea and vomiting and diarrhoea, also have the generation of jaundice phenomenon; Tetracycline antibiotics easily causes intestines and stomach discomfort, photophobia, tetracycline pigmentation teeth, trimester of pregnancy mother and baby genotoxic potential; Chloromycetin is a kind of complete synthesis antibiotic, mainly for various sensitive organism, but because it can cause granulocyte and thrombocytopenia, aplastic anemia etc., use of a specified duration can cause optic neuritis, ataxia and superinfection etc., neonate can cause grey baby's syndrome, and mental patient can cause severe reaction, and intramuscular injection easily causes severe reaction, therefore forbidding, substantially need not at present; Quinolinones can cause the phenomenon of feeling sick, tendon is degenerated; Sulfa drugs easily causes the symptom of the reduction of nausea,vomiting,diarrhea, irritated erythra, urinary crystal, renal failure, numeration of leukocyte and photophobia.Therefore, at present or once conventional antibacterial in use more or less there is side effect, comparatively large on the physical and mental health impact of patient, and there is no the reliable and secure antibacterials of desirable curative effect at present.
Summary of the invention
The invention provides a kind of allicin injection causes infectious disease medicament application as preparation treatment fungus/antibacterial, overcome the deficiency of above-mentioned prior art, it can effectively solve the problem that there is no the reliable and secure antibacterials of desirable curative effect at present.
Technical scheme of the present invention is realized by following measures: a kind of allicin injection causes the application of infectious disease medicament as preparation treatment fungus/antibacterial.
Here is the further optimization and/or improvements to foregoing invention technical scheme:
Above-mentioned treatment fungus/antibacterial causes infectious disease medicament to be allicin injection.
Above-mentioned fungus is Candida albicans, Cryptococcus histolyticus, alpha fungus, trichophyton, acrothesium floccosum, Aspergillus fumigatus, Oidium tropicale and Torulopsis glabrata, and antibacterial is escherichia coli, methicillin-resistant staphylococcus aureus, streptococcus pyogenes, Rhodopseudomonas and helicobacter pylori.
The preparation method of above-mentioned allicin injection is the Chinese patent literature of 102058527A with reference to patent publication No..
The present invention is by showing the test of allicin antibacterial activity, the antibacterial activity that allicin is directed to fungus or antibacterial all has certain effect, illustrate that allicin all has certain effect for the antibacterial activity of fungus or antibacterial, further illustrate allicin injection and can become the new pharmaceutical formulation that a kind of effective treatment fungus/antibacterial causes infectious disease, simultaneously, because allicin is natural materials, nonhazardous side effect, causes infectious disease medicament to have safe and reliable, eutherapeutic effect as treatment fungus/antibacterial.
Accompanying drawing explanation
Fig. 1 is the relational expression schematic diagram that in the present invention, allinase catalytic pyrolysis alliin produces allicin.
Fig. 2 is alliin chemical constitution schematic diagram in the present invention.
Fig. 3 is allicin chemical constitution schematic diagram in the present invention.
Fig. 4 is garlicin chemical constitution schematic diagram in the present invention.
Fig. 5 is the relation schematic diagram of alliin in the present invention, allinase, allicin and diallyl sulfide (ally sulfides).
Detailed description of the invention
The present invention by the restriction of following embodiment, can not determine concrete embodiment according to technical scheme of the present invention and practical situation.
Below in conjunction with embodiment and accompanying drawing, the invention will be further described:
Embodiment 1, this allicin injection causes the application of infectious disease medicament as preparation treatment fungus/antibacterial.
Embodiment 2, preferred as above-described embodiment, treatment fungus/antibacterial causes infectious disease medicament to be allicin injection.
Embodiment 3, preferred as above-described embodiment, fungus is Candida albicans, Cryptococcus histolyticus, alpha fungus, trichophyton, acrothesium floccosum, Aspergillus fumigatus, Oidium tropicale and Torulopsis glabrata, and antibacterial is escherichia coli, methicillin-resistant staphylococcus aureus, streptococcus pyogenes, Rhodopseudomonas and helicobacter pylori.
Embodiment 4, preferred as above-described embodiment, the preparation method of allicin injection is the Chinese patent literature of 102058527A with reference to patent publication No..
Allicin injection causes the antibacterial activity of the application of infectious disease medicament to test as preparation treatment fungus/antibacterial:
1, experimental strain: fungus: Candida albicans, Cryptococcus histolyticus, alpha fungus, trichophyton, acrothesium floccosum, Aspergillus fumigatus, Oidium tropicale and Torulopsis glabrata; Antibacterial: escherichia coli, methicillin-resistant staphylococcus aureus, streptococcus pyogenes, Rhodopseudomonas and helicobacter pylori.
2, test method:
2.3.1, allicin injection preparation allicin is for examination mother solution (simulation allicin injection intravenously administrable)
Get allicin injection Amp mono-(5mg/ml × 5ml).Accurate sucking-off 2.5ml, puts in 25.0ml volumetric flask, adds sterile water for injection and be diluted to scale.Shake up, obtain 500 μ g/ml allicins for examination mother solution, 0 DEG C to 4 DEG C preservation, used in one week.
2.3.2, MIC and IC
50mensuration
(1), the preparation of pastille culture medium
Antibacterial MIC (minimal inhibitory concentration) and IC
50(half Mlc) measures, adopt meat soup that allicin is supplied examination mother solution doubling dilution in test tube, make the final concentration of each pipe be respectively 512mg/L, 256mg/L, 128mg/L, 6mg/L 4,32mg/L, 16mg/L, 8mg/L, 4mg/L, 2mg/L and 1mg/L.
Fungus MIC (minimal inhibitory concentration) measures and adopts RPMI 1640 fluid medium (containing glutamine, not potassium-containing hydrogen salt, containing phenol red as pH indicator, take final concentration as the MOPS of 0.165mmol/L be buffer agent), allicin is 64mg/L, 32mg/L, 16mg/L, 8mg/L, 4mg/L, 2mg/L, 1mg/L, 0.5mg/L, 0.25mg/L and 0.125mg/L for the concentration series after the dilution of examination mother solution).
(2), the preparation of bacteria suspension
The preparation of Bacteria suspension: on blood plate in picking Bacteria planting to be checked incarnation soup, adopt direct bacteria suspension legal system for bacteria suspension, carry out than turbid with McFarland opacity tube, and be adjusted to No. 0.5 McFarland turbidity, then for subsequent use after 1:200 dilution.
The preparation of fungus bacteria suspension: picking bacterium to be checked bacterium colony kind enters in husky Borrow's meat soup on husky Borrow's flat board, meat soup enrichment is adopted to prepare bacteria suspension, carry out than turbid with McFarland opacity tube, and be adjusted to No. 0.5 McFarland turbidity, then for subsequent use after 1:200 dilution.
2.3.3, result of the test measure
By the allicin after bacteria suspension and each dilution for examination mother solution mixed in equal amounts, 35 DEG C, antibacterial cultivates 16 h to 20h, and fungus 35 DEG C cultivates the rear reading result of about 48h, has no the lowest concentration of drug of growth for minimal inhibitory concentration MIC with naked eyes, draw each pipe bacterium liquid respectively and carry out colony counting, calculate IC
50.Experimental result is in data result in table 1 and table 2.
The half Mlc of table 1, allicin antibacterial activity
| Bacterial strain | IC 50Value (μ g/ml) |
| Escherichia coli | 15-17 |
| Methicillin-resistant staphylococcus aureus | 12-17 |
| Streptococcus pyogenes | 3-17 |
| Rhodopseudomonas | 15-17 |
| Helicobacter pylori | 6-18 |
| Aspergillus fumigatus | 8-12 |
| Candida albicans | 0.8-17 |
| Cryptococcus histolyticus | 0.3-17 |
| Oidium tropicale | 0.3-17 |
| Torulopsis glabrata | 1.9-17 |
The minimal inhibitory concentration (MIC, μ g/ml) of table 2, allicin antibacterial activity
| Bacterial strain | Culture medium | First day MIC | Second day MIC | 3rd day MIC |
| Candida albicans | A | 1.57 | 1.57 | 3.13 |
| Candida albicans | B | 0.2 | 3.13 | 3.13 |
| Cryptococcus histolyticus | A | - | 0.79 | 3.13 |
| Cryptococcus histolyticus | B | - | 1.57 | 1.57 |
| Alpha fungus | A | - | 1.57 | 3.13 |
| Alpha fungus | B | - | 1.57 | 3.13 |
| Trichophyton | A | - | 0.79 | 1.57 |
| Trichophyton | B | - | 3.13 | 6.25 |
| Acrothesium floccosum | A | - | - | 0.78 |
| Acrothesium floccosum | B | - | 1.57 | 1.57 |
A, SG agar culture medium, pH 5.6; B, SG broth bouillon, pH 5.6
As can be seen from above-mentioned test data, the antibacterial activity that allicin is directed to fungus or antibacterial all has certain effect, illustrate that allicin all has certain effect for the antibacterial activity of fungus or antibacterial, further illustrate allicin injection and can become the new pharmaceutical formulation that a kind of effective treatment fungus/antibacterial causes infectious disease, simultaneously, because allicin is natural materials, nonhazardous side effect, causes infectious disease medicament to have safe and reliable, eutherapeutic effect as treatment fungus/antibacterial.
Above technical characteristic constitutes embodiments of the invention, and it has stronger adaptability and implementation result, can increase and decrease non-essential technical characteristic according to actual needs, meet the demand of different situations.
Claims (5)
1. an allicin injection treats as preparation the application that fungus/antibacterial causes infectious disease medicament.
2. allicin injection according to claim 1 causes the application of infectious disease medicament as preparation treatment fungus/antibacterial, it is characterized in that treatment fungus/antibacterial causes infectious disease medicament to be allicin injection.
3. allicin injection according to claim 1 and 2 causes the application of infectious disease medicament as preparation treatment fungus/antibacterial, it is characterized in that fungus is Candida albicans, Cryptococcus histolyticus, alpha fungus, trichophyton, acrothesium floccosum, Aspergillus fumigatus, Oidium tropicale and Torulopsis glabrata, antibacterial is escherichia coli, methicillin-resistant staphylococcus aureus, streptococcus pyogenes, Rhodopseudomonas and helicobacter pylori.
4. allicin injection according to claim 1 and 2 causes the application of infectious disease medicament as preparation treatment fungus/antibacterial, it is characterized in that the preparation method of allicin injection is the Chinese patent literature of 102058527A with reference to patent publication No..
5. allicin injection according to claim 3 causes the application of infectious disease medicament as preparation treatment fungus/antibacterial, it is characterized in that the preparation method of allicin injection is the Chinese patent literature of 102058527A with reference to patent publication No..
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410622901.4A CN104434781A (en) | 2014-11-08 | 2014-11-08 | Application of allicin injection in preparation of medicines for treating infectious diseases caused by fungi/bacteria |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410622901.4A CN104434781A (en) | 2014-11-08 | 2014-11-08 | Application of allicin injection in preparation of medicines for treating infectious diseases caused by fungi/bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104434781A true CN104434781A (en) | 2015-03-25 |
Family
ID=52882051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410622901.4A Pending CN104434781A (en) | 2014-11-08 | 2014-11-08 | Application of allicin injection in preparation of medicines for treating infectious diseases caused by fungi/bacteria |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104434781A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108434307A (en) * | 2018-03-09 | 2018-08-24 | 新疆埃乐欣药业有限公司 | Antipruritic anti-acne garlic ointment of inhibiting bacteria and diminishing inflammation and its preparation method and application |
| CN113101284A (en) * | 2021-04-08 | 2021-07-13 | 广州医科大学附属第一医院 | Application of allicin in preparation of anti-yeast drugs |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003024437A1 (en) * | 2001-09-21 | 2003-03-27 | Stone Island Holdings Ltd | Allicin |
| CN101549152A (en) * | 2009-02-13 | 2009-10-07 | 新疆埃乐欣药业有限公司 | Alliin/alliinase dualistic drug-releasing multilayer tablet that can resist infection diseases caused by helicobacter pylori and candida albicans and the like |
| WO2010063998A2 (en) * | 2008-12-01 | 2010-06-10 | Isis Innovation Limited | Antibiotic nanomaterial |
| CN102058527A (en) * | 2010-06-22 | 2011-05-18 | 新疆埃乐欣药业有限公司 | Preparation method and low-temperature continuous stirring ultrafiltration device for anti-tumor and anti-infection allicin injection |
-
2014
- 2014-11-08 CN CN201410622901.4A patent/CN104434781A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003024437A1 (en) * | 2001-09-21 | 2003-03-27 | Stone Island Holdings Ltd | Allicin |
| WO2010063998A2 (en) * | 2008-12-01 | 2010-06-10 | Isis Innovation Limited | Antibiotic nanomaterial |
| CN101549152A (en) * | 2009-02-13 | 2009-10-07 | 新疆埃乐欣药业有限公司 | Alliin/alliinase dualistic drug-releasing multilayer tablet that can resist infection diseases caused by helicobacter pylori and candida albicans and the like |
| CN102058527A (en) * | 2010-06-22 | 2011-05-18 | 新疆埃乐欣药业有限公司 | Preparation method and low-temperature continuous stirring ultrafiltration device for anti-tumor and anti-infection allicin injection |
Non-Patent Citations (1)
| Title |
|---|
| 李新霞，等: "大蒜辣素( 二烯丙基硫代亚磺酸酯) 性质及相关研究进展", 《天然产物研究与开发》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108434307A (en) * | 2018-03-09 | 2018-08-24 | 新疆埃乐欣药业有限公司 | Antipruritic anti-acne garlic ointment of inhibiting bacteria and diminishing inflammation and its preparation method and application |
| CN113101284A (en) * | 2021-04-08 | 2021-07-13 | 广州医科大学附属第一医院 | Application of allicin in preparation of anti-yeast drugs |
| CN113101284B (en) * | 2021-04-08 | 2022-03-08 | 广州医科大学附属第一医院 | Application of allicin in preparation of anti-yeast drugs |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hübsch et al. | Interactive antimicrobial and toxicity profiles of conventional antimicrobials with Southern African medicinal plants | |
| Goncagul et al. | Antimicrobial effect of garlic (Allium sativum) | |
| KR20180008305A (en) | Cytoprotective composition for protection of cell containing Cyclo His-Pro as Active Ingredient | |
| CN101040995A (en) | Valid target of garlic oil and the application in preparing many kinds of medicine | |
| Tshibangu et al. | Chemical composition and bioactivity of Canarium schweinfurthii stem bark extracts from DR Congo against Sickle cell disease and associated bacteria | |
| CN104434781A (en) | Application of allicin injection in preparation of medicines for treating infectious diseases caused by fungi/bacteria | |
| Raghavendra et al. | In vitro antimicrobial activity of various plant latex against resistant human pathogens | |
| Salido et al. | Composition of secondary metabolites in Mexican plant extracts and their antiproliferative activity towards cancer cell lines | |
| Latha et al. | Antimicrobial, antidiarrhoeal and analysis of phytochemical constituents of Sphaeranthus amaranthoides | |
| CN110882302B (en) | Natural composition for reducing uric acid, application thereof and xanthine oxidase inhibitor | |
| Isitua et al. | In vitro Antifungal Activity of Moringa oleifera Lam Leaf on some selected clinical fungal strains | |
| CN104491850A (en) | Application of allicin multilayer enteric-coated tablet to prepare medicines treating infectious diseases caused by fungi/bacteria | |
| KR102472951B1 (en) | A composition for immune enhancement comprising narrow-leaf erecta fig extract mixture | |
| CN103040897B (en) | Application of Qingkailing active component radix isatidis extract in preparation of anti-multidrug-resistant bacterium medicine | |
| Gheith et al. | Assessment of the antimicrobial potential of the hydro-methanolic extract of Sidr (Ziziphus spina-christi) plant against selected pathogens in vitro | |
| Awosan et al. | Antimicrobial potential of Rothmannia longiflora Salisb and Canna indica Linn extracts against selected strains of fungi and bacteria | |
| CN104490857B (en) | Allicin parenteral solution is as the application for preparing treatment myocardial infarction disease medicament | |
| Rao et al. | In vitro investigation on antimicrobial activity of Gloriosa superba Linn tubers against major food borne pathogens | |
| Tamilselvi et al. | Studies on estimation of berberine and antimicrobial activity of different extracts of berberis aristata DC | |
| Igwenyi | Phytochemical analysis and vitamin composition of Irvigna gabonesis and Citrullus colocynthis | |
| Damisa et al. | Investigating the toxicity and antimicrobial activity of Garcina kola extract | |
| Oshomoh et al. | Nutritional compositions and antimicrobial sensitivities of Aqueous extracts of Zingiber officinale ROSC and Allium sativum L on oral microorganisms. | |
| Satorov et al. | Comparative characteristics of antibacterial activity of plants growing in the central part of the Republic of Tajikistan | |
| Mashhadi et al. | Antifungal effects of the extracts of the shallots and artichokes on Candida albicans | |
| Aja et al. | Comparative Amino Acid Compositions of Uvaria chamae Stem Bark and Poly Herbal Mixture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150325 |
|
| RJ01 | Rejection of invention patent application after publication |